Home/Filings/4/0001415889-25-006587
4//SEC Filing

Thakkar Roopal 4

Accession 0001415889-25-006587

CIK 0001551152other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:00 PM ET

Size

4.5 KB

Accession

0001415889-25-006587

Insider Transaction Report

Form 4
Period: 2025-02-28
Thakkar Roopal
EVP, R&D and CSO
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2025-02-28$205.02/sh4,678$959,08442,276 total

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0002004979

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:00 PM ET
Size
4.5 KB